BridgeBio Oncology Therapeutics (BBOT) Shares Outstanding (Diluted) (2023 - 2026)
BridgeBio Oncology Therapeutics (BBOT) posted Shares Outstanding (Diluted) of 80.05 million for Q2 2026, up 323.4% from 18.91 million a year earlier and up 157.0% from the prior quarter.
Powered by 
Analysis
BridgeBio Oncology Therapeutics (BBOT) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
For FY2025, BridgeBio Oncology Therapeutics' Shares Outstanding (Diluted) came in at 31.14 million, up 46.7% from FY2024.
- In prior years, BridgeBio Oncology Therapeutics' Shares Outstanding (Diluted) was 21.24 million in FY2024 (+430.9%) and 4 million in FY2023.
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2023.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased in each of the last four quarters, with growth averaging 137.4% over the last seven quarters.
- According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 31.14 million (Q1 2026), 31.14 million (Q4 2025) and 43.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | BridgeBio Oncology Therapeutics | 328.47 Mn | -1.04 Bn | - | 80.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.05 Mn |
| Mar 31, 2026 | 31.14 Mn |
| Dec 31, 2025 | 31.14 Mn |
| Sep 30, 2025 | 43.49 Mn |
| Jun 30, 2025 | 18.91 Mn |
| Mar 31, 2025 | 18.91 Mn |
| Dec 31, 2024 | 21.24 Mn |
| Sep 30, 2024 | 23.51 Mn |
| Jun 30, 2024 | 23.51 Mn |
| Mar 31, 2024 | 14.47 Mn |
| Dec 31, 2023 | 4.00 Mn |
API Access
BridgeBio Oncology Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BBOT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "BBOT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BBOT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();